Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening
Balloon
Cost of Inpatient Care for Women Undergoing Outpatient vs. Inpatient Transcervical Balloon Cervical Ripening for Induction of Labor at Term
1 other identifier
interventional
140
1 country
1
Brief Summary
The objective of this study is to determine the impact of outpatient cervical ripening with transcervical balloon placement for induction of labor at term on the length and cost of inpatient hospitalization when compared to inpatient cervical ripening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 8, 2021
CompletedFirst Posted
Study publicly available on registry
August 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedMay 31, 2025
May 1, 2025
2.6 years
December 8, 2021
May 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The length of time (measured in minutes) spent on the inpatient unit from admission from cervical ripening and/or labor induction until delivery.
The length of time (measured in minutes) spent on the inpatient unit (L\&D) from admission for cervical ripening and/or labor induction until delivery.
12 months
Cost Analysis in dollars Cost/charges will be calculated for the time spent in the outpatient and inpatient unit for both randomization groups.
Cost Analysis in dollars Cost/charges will be calculated for the time spent in the outpatient and inpatient unit for both randomization groups. Cost will be based on information obtained from Enterprise Analytics charges for the time each woman spends in outpatient care, inpatient care, hospitalized from admission to the L\&D unit to delivery.
12 months
Secondary Outcomes (12)
Delivery
12 months
Maternal state
12 months
Neonatal State
12 months
Maternal Adverse events
12 months
Neonatal adverse events
12 months
- +7 more secondary outcomes
Study Arms (2)
Outpatient cervical ripening
EXPERIMENTALPlacement of transcervical Foley balloon for cervical ripening in outpatient setting
Inpatient cervical ripening
ACTIVE COMPARATORPlacement of transcervical Foley balloon for cervical ripening in inpatient setting
Interventions
Cervical ripening with balloon placement in the outpatient setting
Cervical ripening with balloon placement in the inpatient setting
Eligibility Criteria
You may qualify if:
- Pregnant women at ≥39 weeks gestation by reliable dating criteria as determined by the American College of Obstetricians and Gynecologists
- Scheduled induction of labor with indication and timing supported by Lehigh Valley Health Network -Labor and Delivery Units (Cedar Crest \& Muhlenberg)
- Singleton gestation
- Cephalic presentation
- Amniotic fluid index normal
- Formal prenatal ultrasound during the pregnancy documenting the absence of placenta previa
- Bishop score \<6 and cervical dilation \<3cm at the time of decision to induce labor
- The woman is able to give appropriate consent and has undergone an informed consent process.
- Maternal age ≥ 18 years old at the time of consent
- English speaking
You may not qualify if:
- Undergoing outpatient antenatal testing for any medical or obstetric condition
- Need for inpatient observation or continuous fetal monitoring during their cervical ripening
- New diagnosis requiring immediate hospitalization for monitoring (such as new onset hypertensive disease of pregnancy)
- Vaginal bleeding
- Active labor
- Premature rupture of membranes
- Uterine tachysystole (\>5 contractions in 10 minutes)
- Non-reassuring fetal heart tracing before Foley placement
- Intrauterine fetal demise diagnosed after enrollment and before placement of balloon
- Contraindication to vaginal delivery, relative or absolute (i.e. transfundal uterine surgery)
- Abnormal placentation including a low lying placenta
- Prior cesarean delivery
- Known fetal major anomaly
- Human immunodeficiency virus, Hepatitis C, or active herpes infection
- Maternal cardiopulmonary disease requiring cardiac monitoring during labor
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lehigh Valley Health Network
Allentown, Pennsylvania, 18105, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice Chair Research, Dept OBGYN, Lehigh Valley Health Network
Study Record Dates
First Submitted
December 8, 2021
First Posted
August 18, 2022
Study Start
November 1, 2021
Primary Completion
May 30, 2024
Study Completion
October 30, 2024
Last Updated
May 31, 2025
Record last verified: 2025-05